% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Eulitz:148860,
author = {J. Eulitz and B. Lutz and P. Wohlfahrt and A. Dutz and W.
Enghardt$^*$ and C. Karpowitz$^*$ and M. Krause$^*$ and E.
G. C. Troost$^*$ and A. Lühr},
title = {{A} {M}onte {C}arlo based radiation response modelling
framework to assess variability of clinical {RBE} in proton
therapy.},
journal = {Physics in medicine and biology},
volume = {64},
number = {22},
issn = {1361-6560},
address = {Bristol},
publisher = {IOP Publ.},
reportid = {DKFZ-2020-00052},
pages = {225020},
year = {2019},
abstract = {The clinical implementation of a variable relative
biological effectiveness (RBE) in proton therapy is
currently controversially discussed. Initial clinical
evidence indicates a variable proton RBE, which needs to be
verified. In this study, a radiation response modelling
framework for assessing clinical RBE variability is
established. It was applied to four selected glioma patients
(grade III) treated with adjuvant radio(chemo)therapy and
who developed late morphological image changes on
T1-weighted contrast-enhanced (T1w-CE) magnetic resonance
(MR) images within approximately two years of
recurrence-free follow-up. The image changes were correlated
voxelwise with dose and linear energy transfer (LET) values
using univariable and multivariable logistic regression
analysis. The regression models were evaluated by the
area-under-the-curve (AUC) method performing a leave-one-out
cross validation. The tolerance dose TD50 at which $50\%$ of
patient voxels experienced toxicity was interpolated from
the models. A Monte Carlo (MC) model was developed to
simulate dose and LET distributions, which includes variance
reduction (VR) techniques to decrease computation time. Its
reliability and accuracy were evaluated based on dose
calculations of the clinical treatment planning system (TPS)
as well as absolute dose measurements performed in the
patient specific quality assurance. Morphological image
changes were related to a combination of dose and LET. The
multivariable models revealed cross-validated AUC values of
up to 0.88. The interpolated TD50 curves decreased with
increasing LET indicating an increase in biological
effectiveness. The MC model reliably predicted average TPS
dose within the clinical target volume as well as absolute
water phantom dose measurements within $2\%$ accuracy using
dedicated VR settings. The observed correlation of dose and
LET with late brain tissue damage suggests considering RBE
variability for predicting chronic radiation-induced brain
toxicities. The MC model simulates radiation fields in
patients precisely and time-efficiently. Hence, this study
encourages and enables in-depth patient evaluation to assess
the variability of clinical proton RBE.},
cin = {L301},
ddc = {530},
cid = {I:(DE-He78)L301-20160331},
pnm = {899 - ohne Topic (POF3-899)},
pid = {G:(DE-HGF)POF3-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:31374558},
doi = {10.1088/1361-6560/ab3841},
url = {https://inrepo02.dkfz.de/record/148860},
}